The sialadenitis market focuses on managing inflammation of the salivary glands, commonly due to infections, autoimmune diseases, or blockages like salivary stones. Treatments range from antibiotics and anti-inflammatory drugs to surgical options, while newer approaches like sialendoscopy and laser therapy are increasingly popular, especially for non-invasive intervention. Recent advancements in diagnostic imaging and minimally invasive procedures are improving outcomes and recovery, fueling interest in innovative solutions. The market’s growth is further driven by a rising prevalence of conditions that weaken immune function, increasing susceptibility to sialadenitis. Key industry players are enhancing treatment options and refining diagnostic tools, advancing the market for sialadenitis management.
